These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 13921808)

  • 1. Leukaemia in Nagasaki atomic bomb survivors from 1945 through 1959.
    TOMONAGA M
    Bull World Health Organ; 1962; 26(5):619-31. PubMed ID: 13921808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer and non-cancer effects in Japanese atomic bomb survivors.
    Little MP
    J Radiol Prot; 2009 Jun; 29(2A):A43-59. PubMed ID: 19454804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leukaemia following childhood radiation exposure in the Japanese atomic bomb survivors and in medically exposed groups.
    Little MP
    Radiat Prot Dosimetry; 2008; 132(2):156-65. PubMed ID: 18936088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thyroid Dysfunction and Autoimmune Thyroid Diseases Among Atomic Bomb Survivors Exposed in Childhood.
    Imaizumi M; Ohishi W; Nakashima E; Sera N; Neriishi K; Yamada M; Tatsukawa Y; Takahashi I; Fujiwara S; Sugino K; Ando T; Usa T; Kawakami A; Akahoshi M; Hida A
    J Clin Endocrinol Metab; 2017 Jul; 102(7):2516-2524. PubMed ID: 28472357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absence of evidence for differences in the dose-response for cancer and non-cancer endpoints by acute injury status in the Japanese atomic-bomb survivors.
    Little MP
    Int J Radiat Biol; 2002 Nov; 78(11):1001-10. PubMed ID: 12456287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiation exposure and circulatory disease risk: Hiroshima and Nagasaki atomic bomb survivor data, 1950-2003.
    Shimizu Y; Kodama K; Nishi N; Kasagi F; Suyama A; Soda M; Grant EJ; Sugiyama H; Sakata R; Moriwaki H; Hayashi M; Konda M; Shore RE
    BMJ; 2010 Jan; 340():b5349. PubMed ID: 20075151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of death among children of atomic bomb survivors after 62 years of follow-up: a cohort study.
    Grant EJ; Furukawa K; Sakata R; Sugiyama H; Sadakane A; Takahashi I; Utada M; Shimizu Y; Ozasa K
    Lancet Oncol; 2015 Oct; 16(13):1316-23. PubMed ID: 26384241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exposure to ionizing radiation and development of bone sarcoma: new insights based on atomic-bomb survivors of Hiroshima and Nagasaki.
    Samartzis D; Nishi N; Hayashi M; Cologne J; Cullings HM; Kodama K; Miles EF; Funamoto S; Suyama A; Soda M; Kasagi F
    J Bone Joint Surg Am; 2011 Jun; 93(11):1008-15. PubMed ID: 21984980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A long-term cohort study of the atomic-bomb survivors.
    Kodama K; Mabuchi K; Shigematsu I
    J Epidemiol; 1996 Aug; 6(3 Suppl):S95-105. PubMed ID: 8800280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of possible modifications to the DS86 dosimetry on neutron risk and relative biological effectiveness.
    Hunter N; Charles MW
    J Radiol Prot; 2002 Dec; 22(4):357-70. PubMed ID: 12546224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for curvilinearity in the cancer incidence dose-response in the Japanese atomic bomb survivors.
    Little MP; Muirhead CR
    Int J Radiat Biol; 1996 Jul; 70(1):83-94. PubMed ID: 8691040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on the Hiroshima and Nagasaki survivors, and their use in estimating radiation risks.
    Muirhead CR
    Radiat Prot Dosimetry; 2003; 104(4):331-5. PubMed ID: 14579889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High incidence of meningioma among Hiroshima atomic bomb survivors.
    Shintani T; Hayakawa N; Hoshi M; Sumida M; Kurisu K; Oki S; Kodama Y; Kajikawa H; Inai K; Kamada N
    J Radiat Res; 1999 Mar; 40(1):49-57. PubMed ID: 10408177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiation and cancer risk in atomic-bomb survivors.
    Kodama K; Ozasa K; Okubo T
    J Radiol Prot; 2012 Mar; 32(1):N51-4. PubMed ID: 22394591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of Diabetes in the Atomic Bomb Survivors: 1969-2015.
    Tatsukawa Y; Cordova K; Yamada M; Ohishi W; Imaizumi M; Hida A; Sposto R; Sakata R; Fujiwara S; Nakanishi S; Yoneda M
    J Clin Endocrinol Metab; 2022 Apr; 107(5):e2148-e2155. PubMed ID: 34918116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Radiation risks. Results of the new evaluation].
    Kellerer AM
    Radiologe; 1991 May; 31(5):227-34. PubMed ID: 1876693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salivary gland tumors among atomic bomb survivors, 1950-1987.
    Saku T; Hayashi Y; Takahara O; Matsuura H; Tokunaga M; Tokunaga M; Tokuoka S; Soda M; Mabuchi K; Land CE
    Cancer; 1997 Apr; 79(8):1465-75. PubMed ID: 9118025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Health effects of atomic bomb radiation].
    Shigematsu I
    Rinsho Byori; 1994 Apr; 42(4):313-9. PubMed ID: 8176838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Workshop Report on Atomic Bomb Dosimetry--Review of Dose Related Factors for the Evaluation of Exposures to Residual Radiation at Hiroshima and Nagasaki.
    Kerr GD; Egbert SD; Al-Nabulsi I; Bailiff IK; Beck HL; Belukha IG; Cockayne JE; Cullings HM; Eckerman KF; Granovskaya E; Grant EJ; Hoshi M; Kaul DC; Kryuchkov V; Mannis D; Ohtaki M; Otani K; Shinkarev S; Simon SL; Spriggs GD; Stepanenko VF; Stricklin D; Weiss JF; Weitz RL; Woda C; Worthington PR; Yamamoto K; Young RW
    Health Phys; 2015 Dec; 109(6):582-600. PubMed ID: 26509626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the risks of cancer incidence and mortality following radiation therapy for benign and malignant disease with the cancer risks observed in the Japanese A-bomb survivors.
    Little MP
    Int J Radiat Biol; 2001 Apr; 77(4):431-64. PubMed ID: 11304437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.